• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

ASH: Roche's antibody-drug conjugate Polivy added to chemo-antibody combo boosts...

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Dec 14, 2021 at 11:22: AM
via Breakthroughs in drug development have begun to unlock the potential of antibody-drug conjugates, therapies designed to better target proteins on tumor cells. Genentech’s Polivy has become an early winner in blood cancer, and now the drugmaker is revealing promising results in getting into patients even sooner.

article source
 




Top Bottom
Back
Quote